Acomplia Weight Loss Pills
Acomplia (Rimonabant/Zimulti) is the new weight loss medication breakthrough from Sanofi-Aventis exceeding Phentermine in it’s ability to help you lose weight. It is a CB1 cannabinoid receptor antagonist and its main avenue of effect is reduction in appetite. Acomplia acts by obstructing the receptors which control the food intake and energy expenditure resulting in reduced appetite. Acomplia also has an added characteristic effect as a smoking cessation aid.
Acomplia (Rimonabant/Zimulti) is the first selective CB1 receptor blocker to be approved for use anywhere in the world. In Europe, it is indicated for use in conjunction with diet and exercise for patients with a body mass index greater than 30, or patients wih a BMI greater than 27 with associated risk factors, such as type 2 diabetes or dyslipidaemia.
Use the BMI Calculator available in this site to find out your body mass index.
Acomplia Side Effects
Side effects in trials on Acomplia were vomiting and nausea.
Acomplia Dosage
Acomplia consists of one tablet taken orally every day before breakfast. It should be swallowed with a full glass of water.
Health Tips
Stop Smoking. Health concerns associated with smoking include cancer, lung disease, early menopause, infertility, and pregnancy complications. Smoking triples the risk of dying from heart disease among those who are middle-aged. Second-hand smoke - smoke that you inhale when others smoke - also affects your health. If you smoke, quit today! Helplines, counseling, medications, and other forms of support are available to help you quit. Read more Health Tips »
